In vitro metabolism of dehydroepiandrosterone (DHEA) to 7α-hydroxy-DHEA and Δ5-androstene-3β,17β-diol in specific regions of the aging brain from Alzheimer's and non-demented patients

Brain Research

Volumn 969, Issue 1-2, 2003, Pages 117-125

  Weill Engerer, Sébastien ^a,b   David, Jean Philippe ^a,c   Sazdovitch, Véronique ^d   Liere, Philippe ^a   Schumacher, Michael ^a   Delacourte, André ^a   Baulieu, Etienne Emile ^a   Akwa, Yvette ^a  

^a INSERM   (France)

^b HÔPITAL ROTHSCHILD   (France)

^c Hôpitaux Universitaires Henri Mondor   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

7 Hydroxy dehydroepiandrosterone; Aging; Alzheimer's disease; Androstenediol; Brain; Dehydroepiandrosterone; Human; Neurosteroid

Indexed keywords

7ALPHA HYDROXYPRASTERONE; AMYLOID; ANDROSTERONE DERIVATIVE; OXYGENASE; PRASTERONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; STEROID; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; BIOSYNTHESIS; BRAIN; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DEMENTIA; DENSITY; FEMALE; FRONTAL CORTEX; GAS CHROMATOGRAPHY; HIPPOCAMPUS; HORMONE METABOLISM; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY; METABOLITE; PRIORITY JOURNAL;

EID: 0347296102     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02288-1     Document Type: Article

References (68)

1. Akwa Y., Baulieu E.E. Neurosteroids: behavioral aspects and physiological implications. J. Soc. Biol. 193:1999;293-298.
2. Akwa Y., Baulieu E.E. Dehydroepiandrosterone sulfate (DHEAS) and dehydroepiandrosterone (DHEA): neuroactive steroids. Curr. Opin. Endocrinol. Diabetes. 7:2000;160-167.
3. Akwa Y., Morfin R.F., Robel P., Baulieu E.E. Neurosteroid metabolism. 7α-Hydroxylation of dehydroepiandrosterone and pregnenolone by rat brain microsomes [published erratum appears in Biochem. J. 1993 (May 1);291(Pt 3):952]. Biochem. J. 288:1992;959-964.
4. Akwa Y., Sananes N., Gouézou M., Robel P., Baulieu E.E., Le Goascogne C. Astrocytes and neurosteroids: metabolism of pregnenolone and dehydroepiandrosterone. Regulation by cell density. J. Cell Biol. 121:1993;135-143.
5. DSM-III-R. Diagnostic and Statistical Manual of Mental Disorders. 3rd Edition, revised Edition:1987;American Psychiatric Association, Washington, DC.
6. Aragno M., Parola S., Brignardello E., Mauro A., Tamagno E., Manti R., Danni O., Boccuzzi G. Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats. Diabetes. 49:2000;1924-1931.
7. Arlt W., Callies F., Koehler I., van Vlijmen J.C., Fassnacht M., Strasburger C.J., Seibel M.J., Huebler D., Ernst M., Oettel M., Reincke M., Schulte H.M., Allolio B. Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion. J. Clin. Endocrinol. Metab. 86:2001;4686-4692.
8. Attal-Khemis S., Dalmeyda V., Michot J.L., Roudier M., Morfin R. Increased total 7α-hydroxy-dehydroepiandrosterone in serum of patients with Alzheimer's disease. J. Gerontol. A Biol. Sci. Med. Sci. 53:1998;B125-132.
9. Bastianetto S., Ramassamy C., Poirier J., Quirion R. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res. Mol. Brain Res. 66:1999;35-41.
10. Baulieu E.E. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Rec. Prog. Horm. Res. 52:1997;1-32.
11. Baulieu E.E., Thomas G., Legrain S., Lahlou N., Roger M., Debuire B., Faucounau V., Girard L., Hervy M.P., Latour F., Leaud M.C., Mokrane A., Pitti-Ferrandi H., Trivalle C., de Lacharriere O., Nouveau S., Rakoto-Arison B., Souberbielle J.C., Raison J., Le Bouc Y., Raynaud A., Girerd X., Forette F. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc. Natl. Acad. Sci. USA. 97:2000;4279-4284.
12. Baulieu E.E., Robel P., Schumacher M. Neurosteroids: beginning of the story. Int. Rev. Neurobiol. 46:2001;1-32.
13. Boudarene M., Legros J.J., Timsit-Berthier M. [Study of the stress response: role of anxiety, cortisol and DHEAs]. Encephale. 28:2002;139-146.
14. Braak H., Braak E. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol. 1:1991;213-216.
15. Braak H., Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging. 16:1995;271-278. discussion 278-284.
16. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
17. Cardounel A., Regelson W., Kalimi M. Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action. Proc. Soc. Exp. Biol. Med. 222:1999;145-149.
18. Compagnone N.A., Mellon S.H. Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proc. Natl. Acad. Sci. USA. 95:1998;4678-4683.
19. Compagnone N.A., Mellon S.H. Neurosteroids: biosynthesis and function of these novel neuromodulators. Front. Neuroendocrinol. 21:2000;1-56.
20. Corpéchot C., Robel P., Axelson M., Sjövall J., Baulieu E.E. Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc. Natl. Acad. Sci. USA. 78:1981;4704-4707.
21. Corpéchot C., Synguélakis M., Talha S., Axelson M., Sjövall J., Vihko R., Baulieu E.E., Robel P. Pregnenolone and its sulfate ester in the rat brain. Brain Res. 270:1983;119-125.
22. Delacourte A., David J.P., Sergeant N., Buee L., Wattez A., Vermersch P., Ghozali F., Fallet-Bianco C., Pasquier F., Lebert F., Petit H., Di Menza C. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology. 52:1999;1158-1165.
23. Diamond D.M., Fleshner M., Rose G.M. The enhancement of hippocampal primed burst potentiation by dehydroepiandrosterone sulfate (DHEAS) is blocked by psychological stress. Stress. 3:1999;107-121.
24. Doostzadeh J., Morfin R. Studies of the enzyme complex responsible for pregnenolone and dehydroepiandrosterone 7 alpha-hydroxylation in mouse tissues. Steroids. 61:1996;613-620.
25. Doostzadeh J., Cotillon A.C., Morfin R. Dehydroepiandrosterone 7α- and 7β-hydroxylation in mouse brain microsomes. Effects of cytochrome P450 inhibitors and structure-specific inhibition by steroid hormones. J. Neuroendocrinol. 9:1997;923-928.
26. Engel S.R., Grant K.A. Neurosteroids and behavior. Int. Rev. Neurobiol. 46:2001;321-348.
27. Ferrario E., Massaia M., Aimo G., Pallavicino di Ceva A., Fabris F. Dehydroepiandrosterone sulfate serum levels: no significance in diagnosing Alzheimer's disease. J. Endocrinol. Invest. 22:1999;81.
28. Flood J.F., Roberts E. Dehydroepiandrosterone sulfate improves memory in aging mice. Brain Res. 448:1988;178-181.
29. Hampl R., Morfin R., Starka L. Minireview: 7-hydroxylated derivatives of dehydroepiandrosterone: what are they good for? Endocr. Regul. 31:1997;211-218.
30. Karishma K.K., Herbert J. Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur. J. Neurosci. 16:2002;445-453.
31. Kishimoto Y. In vitro transformation of dehydroepiandrosterone or its sulphate into androstenediol or its sulphate by rat brain and blood preparations. J. Neurochem. 20:1973;211-223.
32. Knapstein P., David A., Wu C.-H., Archer D.F., Flickinger G.L., Touchstone J.C. Metabolism of free and sulfoconjugated DHEA in brain tissue in vivo and in vitro. Steroids. 11:1968;885-896.
33. A receptors by endogenous and synthetic neuroactive steroids. Brain Res. Brain Res. Rev. 37:2001;68-80.
34. Lane M.A., Ingram D.K., Ball S.S., Roth G.S. Dehydroepiandrosterone sulfate: a biomarker of primate aging slowed by calorie restriction. J. Clin. Endocrinol. Metab. 82:1997;2093-2096.
35. Lathe R. Steroid and sterol 7-hydroxylation: ancient pathways. Steroids. 67:2002;967-977.
36. Leblhuber F., Neubauer C., Peichl M., Reisecker F., Steinparz F.X., Windhager E., Dienstl E. Age and sex differences of dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels in normal controls and Alzheimer's disease (AD). Psychopharmacology (Berlin). 111:1993;23-26.
37. Li H., Klein G., Sun P., Buchan A.M. Dehydroepiandrosterone (DHEA) reduces neuronal injury in a rat model of global cerebral ischemia. Brain Res. 888:2001;263-266.
38. Liere P., Akwa Y., Weill-Engerer S., Eychenne B., Pianos A., Robel P., Sjovall J., Schumacher M., Baulieu E.E. Validation of an analytical procedure to measure trace amounts of neurosteroids in brain tissue by gas chromatography-mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 739:2000;301-312.
39. Loria R.M. Immune up-regulation and tumor apoptosis by androstene steroids. Steroids. 67:2002;953-966.
40. Mao X., Barger S.W. Neuroprotection by dehydroepiandrosterone-sulfate: role of an NFkB-like factor. Neuroreport. 9:1998;759-763.
41. Maurice T., Su T.P., Privat A. Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate b25-35-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience. 83:1998;413-428.
42. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
43. Morales A.J., Nolan J.J., Nelson J.C., Yen S.S. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age [published erratum appears in J. Clin. Endocrinol. Metab. 80(9 Sept.) (1995) 2799]. J. Clin. Endocrinol. Metab. 78:1994;1360-1367.
44. Morfin R., Courchay G. Pregnenolone and dehydroepiandrosterone as precursors of native 7-hydroxylated metabolites which increase the immune response in mice. J. Steroid Biochem. Mol. Biol. 50:1994;91-100.
45. Morfin R., Starka L. Neurosteroid 7-hydroxylation products in the brain. Int. Rev. Neurobiol. 46:2001;79-95.
46. Morfin R., Lafaye P., Cotillon A.C., Nato F., Chmielewski V., Pompon D. 7α-Hydroxy-dehydroepiandrosterone and immune response. Ann. NY Acad. Sci. 917:2000;971-982.
47. Morley J.E., Kaiser F., Raum W.J., Perry H.M. 3rd, Flood J.F., Jensen J., Silver A.J., Roberts E. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Proc. Natl. Acad. Sci. USA. 94:1997;7537-7542.
48. Orentreich N., Brind J.L., Vogelman J.H., Andres R., Baldwin H. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J. Clin. Endocrinol. Metab. 75:1992;1002-1004.
49. Padgett D.A., Loria R.M. In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol, and androstenetriol. J. Immunol. 153:1994;1544-1552.
50. Peltoketo H., Luu-The V., Simard J., Adamski J. 17beta-Hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes. J. Mol. Endocrinol. 23:1999;1-11.
51. Racchi M., Govoni S., Solerte S.B., Galli C.L., Corsini E. Dehydroepiandrosterone and the relationship with aging and memory: a possible link with protein kinase C functional machinery. Brain Res. Brain Res. Rev. 37:2001;287-293.
52. Robel P., Bourreau E., Corpechot C., Dang D.C., Halberg F., Clarke C., Haug M., Schlegel M.L., Synguelakis M., Vourch C., et al. Neuro-steroids: 3β-hydroxy-Δ5-derivatives in rat and monkey brain. J. Steroid. Biochem. 27:1987;649-655.
53. Rose K.A., Stapleton G., Dott K., Kieny M.P., Best R., Schwarz M., Russell D.W., Bjorkhem I., Seckl J., Lathe R. Cyp7β, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7α-hydroxy dehydroepiandrosterone and 7α-hydroxy pregnenolone. Proc. Natl. Acad. Sci. USA. 94:1997;4925-4930.
54. Rupprecht R., Holsboer F. Neuropsychopharmacological properties of neuroactive steroids. Steroids. 64:1999;83-91.
55. Schumacher M., Akwa Y., Guennoun R., Robert F., Labombarda F., Desarnaud F., Robel P., DeNicola A., Baulieu E.E. Steroid synthesis and metabolism in the nervous system: trophic and protective effects. J. Neurocytol. 29:2000;307-326.
56. Schumacher M., Akwa Y., Guennoun R., Robert F., Robel P., Baulieu E.E. Neurosteroïdes: progrès récents. Mt Endocrinologie. 3:2001;74-84.
57. Steckelbroeck S., Watzka M., Stoffel-Wagner B., Hans V.H., Redel L., Clusmann H., Elger C.E., Bidlingmaier F., Klingmuller D. Expression of the 17β-hydroxysteroid dehydrogenase type 5 mRNA in the human brain. Mol. Cell Endocrinol. 171:2001;165-168.
58. Steckelbroeck S., Watzka M., Lutjohann D., Makiola P., Nassen A., Hans V.H., Clusmann H., Reissinger A., Ludwig M., Siekmann L., Klingmuller D. Characterization of the dehydroepiandrosterone (DHEA) metabolism via oxysterol 7α-hydroxylase and 17-ketosteroid reductase activity in the human brain. J. Neurochem. 83:2002;713-726.
59. Stoffel-Wagner B. Neurosteroid metabolism in the human brain. Eur. J. Endocrinol. 145:2001;669-679.
60. Stoffel-Wagner B., Watzka M., Steckelbroeck S., Schramm J., Bidlingmaier J.F., Klingmuller D. Expression of 17β-hydroxysteroid dehydrogenase types 1, 2, 3 and 4 in the human temporal lobe. J. Endocrinol. 160:1999;119-126.
61. Vallée M., Mayo W., Le Moal M. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging. Brain Res. Brain Res. Rev. 37:2001;301-312.
62. Verwer R.W., Hermens W.T., Dijkhuizen P., Ter Brake O., Baker R.E., Salehi A., Sluiter A.A., Kok M.J., Muller L.J., Verhaagen J., Swaab D.F. Cells in human postmortem brain tissue slices remain alive for several weeks in culture. FASEB J. 16:2002;54-60.
63. Weill-Engerer S., David J.P., Sazdovitch V., Liere P., Eychenne B., Pianos A., Schumacher M., Delacourte A., Baulieu E.E., Akwa Y. Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients. J. Clin. Endocrinol. Metab. 87:2002;5138-5143.
64. Wolf O.T., Kirschbaum C. Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans. Brain Res. Brain Res. Rev. 30:1999;264-288.
65. Wolf O.T., Kirschbaum C. Dehydroepiandrosterone replacement in elderly individuals: still waiting for the proof of beneficial effects on mood or memory. J. Endocrinol. Invest. 22:1999;316.
66. Wozniak A., Hutchison R.E., Morris C.M., Hutchison J.B. Neuroblastoma and Alzheimer's disease brain cells contain aromatase activity. Steroids. 63:1998;263-267.
67. Yanase T., Fukahori M., Taniguchi S., Nishi Y., Sakai Y., Takayanagi R., Haji M., Nawata H. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) in Alzheimer's disease and in cerebrovascular dementia. Endocr. J. 43:1996;119-123.
68. Zhang L., Li B., Ma W., Barker J.L., Chang Y.H., Zhao W., Rubinow D.R. Dehydroepiandrosterone (DHEA) and its sulfated derivative (DHEAS) regulate apoptosis during neurogenesis by triggering the Akt signaling pathway in opposing ways. Brain Res. Mol. Brain Res. 98:2002;58-66.